JPRN-UMIN000051193
尚未招募
未知
Aripiprazole dose reduction in stable schizophrenia - Aripiprazole dose reduction in stable schizophrenia
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Keio University
- 入组人数
- 100
- 状态
- 尚未招募
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •(1\) Having a history of obvious harm to him/herself and/or others (2\) Having significant physical or neurological illnesses (3\) Having a diagnose of mental and behavioral disorders due to psychoactive substance use according to ICD\-10 (4\) Being pregnant or lactating (5\) Having been judged as unable to provide informed consent by a person who explains the study (6\) Being prohibited to receive reimbursement (in cases such as receiving public assistance and being prohibited from receiving reimbursement by the public assistance case worker) (7\) Having been judged as unsuitable for the study for other reasons by the principal investigator
结局指标
主要结局
未指定
相似试验
已完成
不适用
Aripiprazole research over schizophrenia patients (both on first episode and recurrence) about its efficacy and influence on cognitive functioschizophreniaJPRN-UMIN000002076Kyoto University Hospital20
招募中
4 期
Treatment of Schizophrenia with Aripiprazole. A one year open-label study.SchizophreniaMental Health - SchizophreniaACTRN12605000394640Associate Professor Krishna Vaddadi40
已完成
4 期
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social AnxietySchizophreniaSchizoaffective DisorderSocial Anxiety DisorderNCT00177008University of Medicine and Dentistry of New Jersey18
已完成
2 期
Aripiprazole Treatment of Prodromal PatientsSchizophreniaPsychosisNCT00237874Yale University15
已完成
4 期
Brexpiprazole for the treatment of acute schizophrenia in the Japanese populatioschizophreniaJPRN-UMIN000032339Fujita Health University School of Medicine100